The present invention is directed to analogs of galanthamine of the structure ##STR1## wherein the R terms are herein defined, for use in treating Alzheimer's disease.

A invenção atual é dirigida aos analogs do galanthamine do ## do ## STR1 da estrutura wherein os termos de R são definidos nisto, para o uso na doença de Alzheimer de tratamento.
 
Web www.patentalert.com

< Resource recovery of waste organic chemicals by thermal catalytic conversion

< Composition for thermal insulating material

> Spherical silica particles and method of production

> III-V semiconductors separate confinement superlattice optoelectronic devices
~ 00073